Imbalance in T-cell and cytokine profiles in patients with relapsing-remitting multiple sclerosis
Language English Country Netherlands Media print
Document type Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't
PubMed
20884014
DOI
10.1016/j.jns.2010.08.053
PII: S0022-510X(10)00420-X
Knihovny.cz E-resources
- MeSH
- Cytokines blood MeSH
- Adult MeSH
- Immunophenotyping methods MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Lymphocyte Count methods statistics & numerical data MeSH
- Multiple Sclerosis, Relapsing-Remitting diagnosis immunology metabolism physiopathology MeSH
- Severity of Illness Index MeSH
- T-Lymphocytes physiology MeSH
- Age Factors MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Controlled Clinical Trial MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Cytokines MeSH
Multiple sclerosis (MS) is characterized by autoimmune attack leading to demyelination of the white matter in the central nervous system with devastating clinical consequences. Several immune-mediated destruction mechanisms were previously proposed including different T-cell subsets but complex view on immune system function in patients with MS is missing. In the present study, T-lymphocyte populations and pro-inflammatory as well as suppressive cytokine profiles were evaluated in detail in previously untreated patients with relapsing-remitting MS (RRMS). CD4(+) and CD8(+) naïve, central memory (Tcm), effector memory (Tem), terminal effector memory (Ttem), CD4(+) regulatory T-cells (Treg) and CD8(+) T-suppressor cells (Ts) were analysed using flow cytometry, and levels of ten plasma cytokines were determined using fluorescent bead-based immunoassay. We evaluated two groups of RRMS with minor (n=33) and major (n=25) clinical impairment and compared them with healthy controls (n=40) in order to detect any correlation between severity of MS clinical symptoms and immune disturbances. Significant differences were noted in CD4(+)CD45RA(+)CCR7(+) naïve T-cells, CD4(+)CD45RO(+)CCR7(-) and CD8(+)CD45RO(+)CCR7(-) Tem cells, while no differences were recognized in Tcm, Ttem, Treg and Ts cells in RRMS patients. Nine out of ten studied cytokines were disturbed in plasma samples of patients with RRMS. In conclusion, we demonstrate complex immune dysbalances in untreated MS patients.
References provided by Crossref.org